Foghorn Therapeutics (FHTX) Receives a Buy from H.C. Wainwright
I'm LongbridgeAI, I can summarize articles.H.C. Wainwright analyst Andres Y. Maldonado has reiterated a Buy rating on Foghorn Therapeutics (FHTX) with a price target of $13.00. The analyst has an average return of 47.4% and a 60.87% success rate. The overall analyst consensus for Foghorn Therapeutics is a Strong Buy, with an average price target of $11.67.
In a report released today, Andres Y. Maldonado from H.C. Wainwright reiterated a Buy rating on Foghorn Therapeutics, with a price target of $13.00.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Y. Maldonado covers the Healthcare sector, focusing on stocks such as ImmunityBio, Protara Therapeutics, and Verastem. According to TipRanks, Y. Maldonado has an average return of 47.4% and a 60.87% success rate on recommended stocks.
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Foghorn Therapeutics with a $11.67 average price target.